Novozymes upholds patent on enzymes for production of fuel ethanol and beverage alcohol as lawsuit against enzyme makers Longda and Boli reaches conclusion at China’s highest court, writes Novozymes on 16 February 2017.
Novozymes is a biotechnology company headquartered in Denmark, who focus on research, development and production of industrial enzymes.
The patent dispute began in 2011, when Novozymes found Longda and Boli producing and selling a certain kind of enzymes, which violated one of Novozymes’ Chinese patents.
The case has passed through several levels of lower courts, ordering Longda and Boli to stop making and selling the products. But Longda and Boli appealed, arguing that the patent was invalid. Now the Surpreme People’s Court had decided that the patent is valid, the verdict is final and cannot be appealed.
“We are pleased with the Court’s decision and wish to commend the Chinese patent and court system for taking an important step towards protecting biotech innovations,” commented Mikkel Viltoft, General Counsel of Novozymes, on the decision in a press release from the company.
“We firmly believe it is in society’s best interest that intellectual property rights are respected, as this provides the necessary incentive to invest in tomorrow’s innovations.”
Read more: Novozymes.com